RxDoctor Payments Data

Amanda Yesvetz, PA

Medical · Bethlehem, PANPI 1225354202

Payments from drug & device makers

$3,340in general payments, 2019–2025

Across 37 payments — averaging $90.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Si-bone, Inc.$433
  • AbbVie$379
  • Medtronic$235
  • AstraZeneca$73
  • Electronic Waveform Lab, Inc.$46
  • plus $70 from 4 others

What the payments were for

  • Travel & lodging$1,59848%
  • Food & beverage$1,74152%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific11$2,104
Si-bone, Inc.4$433
AbbVie(2 entities)10$379
Medtronic3$235
AstraZeneca1$73
Electronic Waveform Lab, Inc.4$46
Saluda Medical Americas, Inc.1$27
Scilex Pharmaceuticals Inc.1$17
Galderma Laboratories, L.p.1$16
ERMI LLC1$10

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,340 in reported general payments places this provider in the 85th percentile of 2,594 medical providers in Pennsylvania.

See all medical providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$124,460
Medicare patients
158
Services billed
6,329

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl48$33,736
Xtampza ErOxycodone Myristate30$14,804
NucyntaTapentadol Hcl13$14,654
BelbucaBuprenorphine Hcl13$10,932
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen240$5,422
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen270$5,019
Oxycodone Hcl301$4,727
Gabapentin285$4,440
Tramadol Hcl ErTramadol Hcl65$3,769
Buprenorphine22$3,002
Pregabalin152$1,958
Morphine Sulfate ErMorphine Sulfate91$1,891
Hydromorphone ErHydromorphone Hcl14$1,300
Tramadol Hcl137$1,079
Baclofen30$904

Paid to pharmacies, not to this prescriber.

Other medical in Bethlehem

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →